Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Half-year Report

7th Feb 2022 07:00

RNS Number : 8132A
K3 Capital Group PLC
07 February 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR

 

7 February 2022

 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

 

Interim Results

 

K3 Capital Group plc, a multi-disciplinary professional services firm providing advisory services to SMEs, today announces its interim results for the six months ended 30 November 2021.

 

Financial highlights

 

· Group revenue £31.2m (H1 2021: £18.0m*) with strong organic growth

· All divisions recording growth in revenues and profits:

o M&A: Revenue £9.8m (H1 2021: £5.9m), EBITDA £5.0m (H1 FY21 £2.9m)

o Tax: Revenue £4.8m (H1 2021: £2.6m), EBITDA £2.4m (H1 FY21 £1.4m)

o Restructuring: Revenue £16.6m (H1 2021: £9.5m*), EBITDA £3.0m (H1 FY21 £2.3m*)

· Group Adjusted EBITDA** £9.4m (H1 2021: £5.8m*)

· Net cash £8.8m (H1 2021: £10.1m)

· Headline earnings per share*** 9.4p (H1 2021: 7.2p*)

· Dividend per share 4.0p (H1 2021: 3.0p)

 

* Restated values post year end audit

** Adjusted for acquisition related costs

*** Headline EPS calculated at an average of 72.1m shares vs 61.7m shares H1 FY21. Adjusted to exclude exceptional items

 

Operational highlights

 

· Building a resilient and diversified group with a broad base of SME clients (H1 c.4,200 invoices at an average value of c.£7,250)

· Excellent organic growth in both revenue and EBITDA in the period vs H1 FY21

· Successful fundraise followed by acquisitions of Knight businesses in H1

· New service line launches starting to contribute and utilise cross selling opportunities

· Senior management team strengthened in line with our future ambitions

· Continued investment in people sees our headcount increase to c.550

· Progressive Dividend policy continues to reward and deliver attractive returns to our shareholders

· Strong foundation of H1 coupled with fast start to H2 gives confidence in delivering market expectations

 

 

Outlook

 

· M&A Division continues to see strong levels of KPI performance, with growing transaction fee pipelines underpinning our expectations for H2 and beyond. December was the most profitable month within the M&A division in FY22 to date

· Tax Division now offers broader service lines and greater scale following the acquisition of Knight R&D and the launch of K3 Tax Advisory. Whilst the pandemic is causing temporary reductions and delays in R&D claim processing, we are encouraged by our growing client base driven by the launch of our new client acquisition model

· Restructuring Division is pleased to see that the insolvency market is showing signs of recovery following the withdrawal of Government support and the unwinding of legislative changes. Whilst there are obvious time delays before these market improvements filter through to financial performance, we continue to build our market share and fee earner base as we look to take advantage of the returning market

· We remain confident that the outlook for the remainder of the financial year, and beyond, is positive and are pleased to report a strong start to H2 FY22

 

Commenting on the results, Chief Executive of K3 Capital Group plc, John Rigby, said:

 

"I am delighted to report that both myself and the Board are extremely satisfied with a strong financial performance during the first half of FY22, with trading comfortably in line with market expectations.

 

"The Group successfully completed the acquisitions of Knight Corporate Finance and Knight R&D in the period, both of which are immediately earnings enhancing. Knight Corporate Finance is a specialist M&A advisory firm within the telecoms and tech sector, and Knight R&D is a specialist research and development ("R&D") tax advisory firm servicing UK SMEs. The Acquisitions are in line with K3's strategy to acquire complementary and value accretive businesses to build out its existing SME focussed service lines, providing the Group with counter-cyclical service lines.

 

"The Board remains confident that the outlook for the remainder of the financial year, and beyond, is positive and is pleased to report a strong start to H2 FY22, with December delivering £6m of revenue and £1.7m EBITDA during a traditionally quieter festive period. We continue to evaluate acquisition targets which could be additive to overall product offering and allow further diversification of Group revenues."

 

 

-ENDS-

 

For further information please contact:

K3 Capital Group plc

Tel: c/o Newgate 020 7680 6550

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

 

 

 

finnCap Ltd (Nominated Adviser and Joint Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Charlie Beeson (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

Canaccord Genuity Limited (Joint Broker)

Tel: 020 7523 8000

Bobbie Hilliam (Corporate Broking)

 

Alex Aylen (Head of Equities)

 

 

SEC Newgate (Financial PR)

Tel: +44 (0) 203 757 6880

Bob Huxford

Axaule Shukanayeva

Isabelle Smurfit

[email protected]

 

 

 

 

Information on K3 Capital Group plc can be accessed via the Group's website at: www.k3capitalgroupplc.com

 

About K3 Capital

K3 Capital Group plc is a multi-disciplinary and complementary professional services group advising UK SMEs, with operations throughout the UK and overseas.

Services provided by the Group fall into three key operating divisions:

· M&A Division:

o Company sales and business brokerage

o Corporate finance services

o Transaction services

o Off-market acquisitions

o Debt advisory

 

· Tax Division:

o Research and development tax credit advisory

o Tax investigations

o Tax planning

o Tax advisory

 

· Restructuring Division:

o Restructuring advisory

o Financial advisory

o Creditor services

o Forensic accounting and expert witness

o Pensions advisory

o Accelerated M&A

 

 

 

 

CEO's Statement

 

Interim Results

 

I am delighted to report that both myself and the Board are extremely satisfied with a strong financial performance during the first half of FY22, with trading in line with market expectations.

 

The Group successfully completed the acquisitions of Knight Corporate Finance and Knight R&D in the period, both of which are immediately earnings enhancing. Knight Corporate Finance is a specialist M&A advisory firm within the telecoms and tech sector, and Knight R&D is a specialist research and development ("R&D") tax advisory firm servicing UK SMEs. The Acquisitions are in line with K3's strategy to acquire complementary and value accretive businesses to build out its existing SME focussed service lines, providing the Group with counter-cyclical service lines.

 

We are very pleased to be reporting Group revenues of £31.2m for H1 FY22 (£18.0m H1 FY21*), which delivered £9.4m of Adjusted EBITDA** for the period (£5.8m H1 FY21*). Net Cash was £8.8m (£10.1m H1 FY21).

 

Headline EPS for the period was 9.4p (7.2p H1 FY21*) having adjusted for costs relating to the acquisition of the Knight businesses in July 2021, with actual EPS 4.9p (1.7p H1 FY21*).

 

* Restated values post year end audit

** Adjusted for acquisition related costs

 

 

Divisional Breakdown

 

6 months ended 30 November

 

2021

 

 

Unaudited

 

 

£million

M&A Division

Revenue

9.8

 

EBITDA

5.0

 

 

 

Tax Division

Revenue

4.8

 

EBITDA

2.4

 

 

 

Restructuring Division

Revenue

16.6

 

EBITDA

3.0

Plc costs (adjusted for acquisition costs)

 

(1.0)

K3 Capital Group plc

Revenue

31.2

 

Adjusted EBITDA

9.4

 

I am pleased to report that all Group companies have traded strongly during the period.

 

Our M&A division increased revenue by 66% in the period compared to the first six months of FY21 and EBITDA by 72%. The acquisition of Knight Corporate Finance inevitably added revenue and profit for the M&A division, however I am particularly pleased with the organic growth within the existing brands, which delivered a 53% increase in revenue, and a 52% increase in EBITDA. The division's innovative use of big data and technology has resulted in the continuing increase in volumes of sell-side clients, new buyer registrations and, ultimately, overall transaction numbers, demonstrated by strong KPIs in the period. Increasing visibility of the division's contingent fee pipeline gives us confidence of a strong H2.

 

Our restructuring division had a successful trading period, reporting an increase in revenue of 75% and an increase in EBITDA of 30%. We are buoyed by the increasing number of insolvency appointments in the market (up 59% vs H1 FY21), and particularly delighted that Quantuma has increased its number of appointments by 40%. This level of activity gives the Board confidence that the division will deliver a strong H2 performance.

We are pleased with the performance of the Tax division, as revenues increased by 85% and EBITDA by 71%. The improved trading performance can be attributed to adding the revenue streams of Intax, Knight R&D and K3 Tax advisory.

 

Dividend

 

The Board is committed to a progressive fixed dividend policy, being a 9.1p dividend per share ("DPS") in FY21, 12.1p DPS in FY22 and 15.5p DPS in FY23. As per previous years, this will be paid approximately 1/3 on interim results and the balance on annual results.

 

Accordingly, the Board is recommending a 4.0p interim dividend per share (FY21: 3.0p). The interim dividend will be paid on 4 March 2022; the record date is 18 February 2022; the ex-dividend date is 17 February 2022.

 

Current Trading and Outlook

The Board is pleased with the Group's H1 FY22 financial performance, especially when taking into account the prolonged effects of the global pandemic on UK SMEs, and therefore expects its full year results will be comfortably in line with market expectations.

 

· Our M&A Division continues to see strong KPI performance, with growing transaction fee pipelines underpinning our expectations for H2 and beyond. December was the most profitable month within the M&A division in FY22 to date.

 

· Our Tax Division now offers broader service lines and greater scale following the acquisition of Knight R&D and the launch of K3 Tax Advisory. Whilst the pandemic is causing both a temporary reduction and delays in R&D claim processing, we are encouraged by our growing client base driven by the launch of our new client acquisition model.

 

· Our Restructuring Division is pleased to see that the insolvency market is showing signs of recovery following withdrawal of Government support and the unwinding of legislative changes. Whilst there are obvious time delays before these market improvements filter through to financial performance, we continue to build our market share and fee earner base as we look to take advantage of the returning market.

 

The Board is confident that the outlook for the remainder of the financial year, and beyond, is positive and is pleased to report a strong start to H2 FY22, with December delivering £6m of revenue and £1.7m EBITDA during a traditionally quieter festive period. We continue to evaluate complementary acquisition targets which could be additive to overall product offering and allow further diversification of Group revenues.

 

John Rigby

Chief Executive Officer

7 February 2022

 

 

 

 

For the 6 months ended 30 November

2021 Unaudited

For the 6 months ended 30

November

2020

Restated unaudited

 

£'000

£'000

Revenue

 

31,244

18,042

Cost of sales

 

(8,506)

(4,482)

 

----------------------------

-----------------------

Gross profit

22,738

13,560

 

Distribution costs

(1,534)

(969)

Administrative expenses

(15,917)

(10,569)

Other income

27

21

 

 

 

 

 

 

 

 

Adjusted EBITDA

9,379

5,829

Share-based payments

(126)

(23)

Depreciation of tangible assets

(472)

(267)

Loss on disposal of tangible assets

(1)

-

Amortisation of intangible assets

(1,095)

(532)

Acquisition costs

(459)

(1,589)

Deemed remuneration

(1,912)

(1,375)

 

 

 

 

 

 

 

 

 

 

----------------------------

-----------------------

Operating profit

 

5,314

2,043

 

Finance income

 

14

2

Finance costs

 

(169)

(101)

 

----------------------------

-----------------------

Finance costs - net

(155)

(99)

 

 

 

Share of net profits of joint ventures accounted for using the equity method

40

16

 

----------------------------

-----------------------

Profit before taxation

5,199

1,960

 

Taxation

 

(1,693)

(928)

 

-----------------------

-----------------------

Profit for the period

3,506

1,032

 

=======================

=======================

 

Other comprehensive income

 

 

Items that may be reclassified to profit or loss

 

 

 

Exchange differences on translation of foreign operations

 

20

(2)

 

-----------------------

-----------------------

Other comprehensive income for the period

20

(2)

 

-----------------------

-----------------------

Total comprehensive income for the period

3,526

1,030

 

=======================

=======================

 

Attributable to:

 

 

Owners of the Company

3,548

1,030

Non-controlling interests

(22)

-

 

-----------------------

-----------------------

 

3,526

1,030

 

=======================

=======================

 

Earnings per share:

 

 

 

Basic

£0.05

£0.02

Diluted

£0.05

£0.02

 

Headline earnings per share:

 

 

 

Headline basic

£0.09

£0.07

Headline diluted

£0.09

£0.07

 

All the activities of the group are from continuing operations.

 

 

 

 

 

As at 30 November 2021

Unaudited

As at 30 November 2020

Restated unaudited

 

 £'000

£'000

ASSETS

Non-current assets

Intangible assets

54,833

42,390

Property, plant and equipment

941

186

Right-of-use assets

2,087

2,342

Investments accounted for using the equity method

3

2

 

-----------------------

-----------------------

Total non-current assets

57,864

44,920

 

-----------------------

-----------------------

 

Current assets

Trade and other receivables

17,680

7,171 05

Other Assets

947

778

Cash and cash equivalents

8,826

10,091

 

-----------------------

-----------------------

Total current assets

27,453

18,040

 

-----------------------

-----------------------

TOTAL ASSETS

85,317

62,960

 

=======================

=======================

 

Current liabilities

Trade and other payables

7,911

6,861

Current tax liabilities

3,746

958

Contract liabilities

1,900

1,189

Lease liabilities

660

520

Contingent consideration

2,197

897

 

-----------------------

-----------------------

Total current liabilities

16,414

10,425

 

-----------------------

-----------------------

 

Non-current liabilities

Lease liabilities

1,333

1,459

Deferred tax liabilities

1,537

1,543

Provisions

395

391

Contingent consideration

2,918

3,331

 

-----------------------

-----------------------

Total non-current liabilities

6,183

6,724

 

-----------------------

-----------------------

TOTAL LIABILITIES

22,597

17,149

 

-----------------------

-----------------------

NET ASSETS

62,720

45,811

 

=======================

=======================

 

EQUITY

Equity attributable to owners of the Company:

Issued capital and share premium

36,282

24,630

Merger reserve

19,231

15,900

Equity-settled employee benefits reserve

828

141

Foreign exchange reserve

(20)

(2)

Retained earnings

6,427

5,142

 

-----------------------

-----------------------

Equity attributable to the owners of the company

62,748

45,811

Non-controlling interests

(28)

-

 

-----------------------

-----------------------

TOTAL EQUITY

62,720

45,811

 

=======================

=======================

 

 

 

 

Share capital

Share premium

Merger reserve

Share Option reserve

Foreign exchange reserve

Retained earnings

Attributable to owners of the parent

Non-controlling interest

Total

 

£000

£000

£000

£000

£000

£000

£000

£000

£000

 

 

 

 

 

 

 

 

 

 

Balance at 1 June 2020

422

1,991

-

118

-

6,715

9,246

-

9,246

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

-

-

-

-

1,032

1,032

-

1,032

Other comprehensive expense

-

-

-

-

(2)

-

(2)

-

(2)

 

-----------------------

--------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

Total comprehensive income for the period

-

-

-

-

(2)

1,032

1,030

-

1,030

 

-----------------------

--------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

Transactions with owners

 

 

 

 

 

 

 

 

 

Issue of ordinary shares, net of transaction costs

156

21,954

-

-

-

-

22,110

-

22,110

Issue of ordinary shares as consideration for a business combination, net of transaction costs

107

-

15,900

-

-

-

16,007

-

16,007

Share-based payments

-

-

-

23

-

-

23

-

23

Dividends

 

-

-

-

-

-

(2,605)

(2,605)

-

(2,605)

 

-----------------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

Balance at 30 November 2020 Restated unaudited

685

23,945

15,900

141

(2)

5,142

45,811

-

45,811

 

-----------------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 June 2021

688

24,275

16,108

896

(40)

7,323

49,250

(6)

49,244

Profit for the period

-

-

-

-

-

3,528

3,528

(22)

3,506

Other comprehensive expense

-

-

-

-

20

-

20

-

20

 

-----------------------

--------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

Total comprehensive income for the period

-

-

-

-

(20)

3,528

3,548

(22)

3,526

 

-----------------------

--------------

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

 

 

 

 

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

 

 

 

 

Issue of ordinary shares, net of transaction costs

35

11,275

-

-

-

-

11,310

-

11,310

Issue of ordinary shares as consideration for a business combination, net of transaction costs

9

-

3,123

-

-

-

3,132

-

3,132

Recognition of share-based payments

-

-

-

(68)

-

41

(27)

-

(27)

Dividends

-

-

-

-

-

(4,465)

(4,465)

-

(4,465)

 

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

Balance at 30 November 2021

732

35,550

19,231

828

(20)

6,427

62,748

(28)

62,720

 

--------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

-----------------------

           

 

 

 

 

 

 

 

For the 6 months ended 30 November

2021 Unaudited

For the 6 months ended 30

November

2020

Restated unaudited

 

 £000

£000

Cash flows from operating activities

Profit for the financial period

3,506

1,032

 

Adjustments for:

 

 

Share of profit of joint ventures

(40)

(16)

Depreciation and amortisation

1,567

799

Loss on disposal of PPE

1

-

Finance costs

155

99

Income tax expense

1,693

928

Expense recognised in respect of equity-settled share based payments

125

23

(Decrease)/increase in deemed remuneration liabilities

(710)

1,375

 

-----------------------

-----------------------

 

6,297

4,240

 

Movements in working capital:

 

 

Increase in trade and other receivables

(3,419)

(1,384)

(Increase)/decrease in other assets

(169)

1,087

(Decrease)/ increase in trade and other payables (excluding deemed remuneration liabilities)

(2,219)

1,531

Increase/(decrease) in contract liabilities

424

(180)

 

-----------------------

-----------------------

Cash generated from operations

914

5,294

 

Finance income received

14

1

Income taxes paid

(881)

(1,081)

 

-----------------------

-----------------------

Net cash from operating activities

47

4,214

 

=======================

=======================

 

Investing activities

Purchase of property, plant and equipment

(357)

(23)

Purchase of intangible assets

(215)

(50)

Dividends received from joint ventures

40

20

Contingent consideration payments

(561)

-

Acquisition of subsidiary

(9,091)

(21,599)

 

-----------------------

-----------------------

Net cash used in investing activities

(10,184)

(21,652)

 

=======================

=======================

 

Financing activities

Repayment of the lease liabilities

(391)

(245)

Lease liability interest paid

(56)

 

Interest paid

(43)

-

Dividends paid

 (4,465)

(2,605)

Proceeds on issue of shares

9,611

22,109

 

-----------------------

-----------------------

Net cash generated from/used in financing activities

4,656

(19,259)

 

=======================

=======================

 

Net increase/(decrease) in cash and cash equivalents

(5,481)

1,821

Cash and cash equivalents at beginning of the period

14,307

8,271

Effect of foreign exchange rate changes

-

(1)

 

-----------------------

-----------------------

Cash and cash equivalents at end of the period

8,826

10,091

 

=======================

=======================

 

 

1. General Information

 

K3 Capital Group PLC is incorporated in England and Wales under the Companies Act (listed on AIM, a market operated by the London Stock Exchange PLC) with the registered number 06102618. The address of the registered office is KBS House, 5 Springfield Court, Summerfield Road, Bolton, BL3 2NT.

 

The interim condensed consolidated financial statements comprise the Company and its subsidiaries "the Group". This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

2. Basis of preparation

The financial information set out in this Interim Report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 May 2021, prepared under IFRS, have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. The interim financial information has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) and on the same basis and using the same accounting policies as used in the financial statements for the year ended 31 May 2021, subject to the introduction of any new accounting standards applicable in the period.

 

The Interim Report has not been audited or reviewed in accordance with the International Standard on Review Engagement 2410 issued by the Auditing Practices Board.

 

3. Significant accounting policies

 

New standards, amendments to and interpretations to published standards which are now effective

 

There were no new standards, interpretations or amendments effective for the first time for periods beginning on or after 1 January 2021 that had a significant effect on the Group's financial statements.

 

4. Critical Accounting Estimates and Sources of Estimation Uncertainty

 

There have been no material revisions to the nature and amount of changes in estimates of amounts reported or any areas of judgements in the annual financial statements for the year ended 31 May 2021.

 

5. Earnings per Share

 

Basic earnings per share amounts are calculated by dividing the profit for the period attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding during the period.

 

The following reflects the income and share data used in the basic and diluted earnings per share computations:

 

 

2021

2020

 

£'000

£'000

Net profit attributable to equity holders of the Company

3,506

1,032

Initial weighted average of ordinary shares

72,143,227

61,701,697

Basic earnings per share

4.86p

1.67p

 

The weighted average number of ordinary shares for the purposes of diluted earnings per share reconciles to the weighted average number of ordinary shares used in the calculation of basic earnings per share as follows:

 

 

2021

2020

Weighted average number of ordinary shares used in the calculation of basic earnings per share

72,143,227

61,701,697

Shares deemed to be issued for no consideration in respect of employee options

5,051,416

396,777

Weighted average number of shares used in the calculation of diluted earnings per share

77,194,643

62,098,474

 

=======================

=======================

Diluted earnings per share

4.54p

1.66p

 

 

2021

2020

Basic headline earnings per share

9.37p

7.23p

Diluted headline earnings per share

8.76p

7.19p

 

The calculation of basic and diluted headline earnings per share is based on the following data:

 

 

2021

2020

 

£000

£000

Net profit attributable to equity holders of the Company

3,506

1,032

Add back/(deduct):

 

 

Acquisition costs

459

1,589

Deemed remuneration

1,912

1,375

Unwinding of discount on contingent consideration

70

62

Amortisation of acquired intangibles

1,049

499

Tax effect of the above

(235)

(95)

 

=======================

=======================

Headline earnings

6,761

4,462

 

6. Dividends

 

Dividends paid on equity shares

 

As at 30 November 2021

As at 30 November 2020

 

£'000

£'000

Ordinary shares

4,465

2,605

 

-----------------------

-----------------------

Total

4,465

2,605

 

=======================

==============

 

7. Revenue and segment information

 

Following acquisitions made in the year, and subsequent group restructure, the Group has 3 main reporting lines:

 

a. M&A Advisory - this division constitutes the original Group companies and is involved in providing corporate finance services to customers.

 

b. Restructuring Advisory - this division is involved in providing funding and corporate recovery services to customers.

 

c. Tax Advisory - this division is involved in providing technical taxation advice, including R&D tax claims and support with HMRC investigations, to customers.

 

Internal management reports are reviewed by the directors on a monthly basis, including revenue information by subsidiary. Such revenue information alone does not constitute sufficient information upon which to base resource allocation decisions. Performance of the segment is assessed based on a number of financial and non-financial KPI's as well as on EBITDA which inform management decisions.

 

Six months ended 30 November 2021

£'000

M&A Advisory

Restructuring Advisory

Tax Advisory

Total

Group's revenue per consolidated statement of comprehensive income

9,835

16,602

4,807

31,244

Depreciation

(130)

(329)

(13)

(472)

Amortisation

(137)

(433)

(525)

(1,095)

Segment profit

4,693

2,284

1,813

8,790

Share-based payments

 

 

 

(126)

Share of post-tax profits of equity accounted joint ventures

 

 

 

40

Finance expense

 

 

 

(169)

Finance income

 

 

 

14

Acquisition costs

 

 

 

(2,371)

Other unallocated central costs

 

 

 

(979)

Group profit before tax

 

 

 

5,199

 

Six months ended 30 November 2020

£'000 Restated unaudited

M&A Advisory

Restructuring Advisory

Tax Advisory

Total

Group's revenue per consolidated statement of comprehensive income

5,913

9,560

2,569

18,042

Depreciation

(124)

(141)

(2)

(267)

Amortisation

(33)

(283)

(216)

(532)

Segment profit

2,695

1,967

1,187

5,849

Share-based payments

 

 

 

(23)

Share of post-tax profits of equity accounted joint ventures

 

 

 

16

Finance expense

 

 

 

(101)

Finance income

 

 

 

2

Acquisition costs

 

 

 

(2,964)

Other unallocated central costs

 

 

 

(819)

Group profit before tax

 

 

 

1,960

 

8. Share-based payments

 

Employee share option plan of the Company

Details of the employee share option plan of the Company

 

The Company has a share option scheme for executives and senior employees of the Company and its subsidiaries. In accordance with the terms of the plan executives and senior employees may be granted options to purchase ordinary shares.

 

Each employee share option converts into one ordinary share of the Company on exercise. No amounts are paid or payable by the recipient on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.

 

The number of options granted is calculated in accordance with the performance-based formula approved by the remuneration committee. The formula rewards executives and senior employees to the extent of the Group's and the individual's achievement judged against both qualitative and quantitative criteria from the following financial measures:

· improvement in adjusted earnings per share

· improvement in return to shareholders

Details of growth share plan of the Company

"Growth Share Awards" are awards granted in the form of an immediate beneficial interest to be held by participants in a discrete and bespoke class of ordinary shares, namely the Growth Shares in K3 Advisory Group Limited. After a minimum period of three or five years, depending on the series in issue, the Growth Shares may be exchanged for new Ordinary Shares or cash (at the Company's discretion), subject to the rules of the plan, continued employment, and meeting certain share price hurdles, which the Remuneration Committee considers to be challenging. If the share price for the 5 day period following the announcement of the Company's financial results for the financial year, indicated below, is below the target, all of the Growth Shares will be bought back by the Company for nominal value. If the share price following the announcement of the Company's financial results for the financial year, indicated below, is above the target, the Growth Shares will vest in full, when each vested Growth Share may be exchanged for an ordinary share in the Company or cash (at the Company's discretion).

 

Growth share option series

Target share price

Relevant financial year end results

(1) Granted on 31 July 2020

£3.00

31 May 2023

(2) Granted on 31 July 2020

£3.50

31 May 2023

(3) Granted on 16 November 2020

£3.50

31 May 2023

(4) Granted on 6 January 2021

£5.00

31 May 2025

(5) Granted on 9 July 2021

£7.00

31 May 2026

 

 

 

 

 

The following share-based payment arrangements were in existence during the current period:

 

Option series

Number

Grant date

Expiry date

Exercise price

Fair value at grant date

 

 

 

 

£

£

Series 1 - granted on 11 April 2017

1,193,611

11/04/2017

11/04/2027

0.95

0.11

Series 2 - granted on 17 January 2018

552,022

17/01/2018

17/01/2028

1.81

0.28

Series 3 - granted on 29 June 2020

666,664

29/06/2020

29/06/2030

1.50

0.29

Growth shares series 1 - granted 31 July 2020

2,116,654

31/07/2020

31/07/2023

0.04

0.15

Growth shares series 2 - granted 31 July 2020

604,761

31/07/2020

31/07/2023

-

0.13

SAYE scheme

455,006

30/10/2020

01/06/2024

1.50

0.22

Growth shares series 3 - granted 16 November 2020

500,000

16/11/2020

16/11/2023

0.02

0.27

Growth shares series 4 - granted 6 January 2021

295,000

06/01/2021

06/01/2026

0.04

0.47

Growth shares series 5 - granted 9 July 2021

850,000

09/07/2021

09/07/2026

0.09

0.71

 

Series 1-3 options and Growth Shares series 1-3 vest over a 3 year performance period, Growth Shares series 4-5 vest over a 5 year performance period. The performance period start date for Series 1 was 1 June 2017, for Series 2 1 December 2017 and for Series 3 1 June 2020. Growth Shares series 1-4 performance period start date was 1 June 2020, Growth Share series 5 performance period start date was 1 June 2021. The earliest expected date for exercise would be after publication of the Group's annual results for the year ending 31 May 2020, in respect of series 1, publication of the Group's interim results for the period ended 30 November 2020, in respect of series 2 and publication of the Group's annual results for the year ending 31 May 2023, in respect of series 3 and Growth shares series 1-3. The earliest expected date for exercise for Growth Shares series 4 would be the publication of the Group's annual results for the year ending 31 May 2025, and for Growth Share series 5 the year ending 31 May 2026.

The SAYE scheme options vest on 1 December 2023 and there are no specific performance criteria to achieve.

 

Cautionary Statement

 

This Interim Report has been prepared solely to provide information to shareholders. The Interim Report should not be relied upon by any party or for any other purpose.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DBGDDXDGDGDL

Related Shares:

K3C.L
FTSE 100 Latest
Value8,275.66
Change0.00